Clinical Trial

TEAPOT Study Multisite

Study acronym: TEAPOT
Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
After a child has their tonsils removed, sometimes they might bleed which can be a problem. There is a special mist medicine called nebulized tranexamic acid (TXA) that might help stop the bleeding without having to touch the sore spot. If this mist works well, it could help kids get better by making sure they don't have to go back for more surgery or need blood from someone else. Not having another surgery is good because it means kids won't have to sleep under medicine again, which can sometimes be risky for their brains and breathing, and they won't feel as scared or hurt.
Protocol Amendment History 1 change
critical Recruitment opened 2026-07-19
Trial Details
NCT Number NCT07565753
Lead Sponsor The University of Texas Health Science Center at San Antonio
Collaborators: National Heart, Lung, and Blood Institute (NHLBI)
Conditions Hemorrhage, Surgical, Tonsillar Bleeding
Enrollment 30 participants
Start Date 2026-07-14
Primary Completion 2027-09-30 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-17